PT2247285E - Agente terapêutico celular para incontinência de urina compreendendo células estaminais originárias de decídua - Google Patents

Agente terapêutico celular para incontinência de urina compreendendo células estaminais originárias de decídua Download PDF

Info

Publication number
PT2247285E
PT2247285E PT88546361T PT08854636T PT2247285E PT 2247285 E PT2247285 E PT 2247285E PT 88546361 T PT88546361 T PT 88546361T PT 08854636 T PT08854636 T PT 08854636T PT 2247285 E PT2247285 E PT 2247285E
Authority
PT
Portugal
Prior art keywords
decidua
incontinence
urine
stem cells
therapeutic agent
Prior art date
Application number
PT88546361T
Other languages
English (en)
Inventor
Jeong Chan Ra
Hang Young Lee
Jung Youn Jo
Yun Jung Kim
Original Assignee
Rnl Bio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rnl Bio Co Ltd filed Critical Rnl Bio Co Ltd
Publication of PT2247285E publication Critical patent/PT2247285E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT88546361T 2007-11-30 2008-12-01 Agente terapêutico celular para incontinência de urina compreendendo células estaminais originárias de decídua PT2247285E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20070124010 2007-11-30

Publications (1)

Publication Number Publication Date
PT2247285E true PT2247285E (pt) 2014-07-25

Family

ID=40679167

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88546361T PT2247285E (pt) 2007-11-30 2008-12-01 Agente terapêutico celular para incontinência de urina compreendendo células estaminais originárias de decídua

Country Status (11)

Country Link
US (2) US20110059052A1 (pt)
EP (1) EP2247285B1 (pt)
JP (1) JP5280451B2 (pt)
KR (1) KR101046188B1 (pt)
CN (1) CN101801352B (pt)
CA (1) CA2692765C (pt)
ES (1) ES2478678T3 (pt)
MX (1) MX2010000394A (pt)
PL (1) PL2247285T3 (pt)
PT (1) PT2247285E (pt)
WO (1) WO2009069991A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8808688B2 (en) * 2009-10-06 2014-08-19 National University Corporation Nagoya University Cell preparation for erectile dysfunction or sensory disorders of the lower urinary tract containing adipose tissue derived mesenchymal stem cells
EP2537922B1 (en) * 2010-02-18 2021-04-21 Kang Stem Biotech Co., Ltd. Cd49f promoting proliferation, multipotency and reprogramming of adult stem cells through pi3k/akt/gsk3 pathway
EP2679231A4 (en) 2011-02-25 2014-08-13 Kyungpook Nat Univ Hospital AGENT FOR THE TREATMENT OF URINARY INCONTINENCE COMPRISING STEM CELLS FROM AMNIOTIC LIQUID
KR101289834B1 (ko) * 2011-02-25 2013-07-24 경북대학교병원 양수 유래 줄기세포를 함유하는 요실금 치료제
CN104508124B (zh) 2011-07-06 2017-11-17 细胞治疗有限公司 中胚层谱系祖细胞
KR101423659B1 (ko) * 2011-12-27 2014-07-28 경북대학교병원 초기 분화된 양수 줄기세포를 포함하는 요실금 치료제
US9700581B2 (en) 2012-09-10 2017-07-11 Wake Forest University Health Sciences Urine stem cells for skeletal muscle generation and uses thereof
ES2827849B2 (es) * 2019-11-22 2022-07-04 Fundacion Para La Investig Biomedica Del Hospital 12 De Octubre Celulas madre de la decidua parietalis de la placenta para su uso en la incontinencia urinaria de esfuerzo cronica

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5516532A (en) * 1994-08-05 1996-05-14 Children's Medical Center Corporation Injectable non-immunogenic cartilage and bone preparation
US5830708A (en) 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
US5654381A (en) * 1995-06-16 1997-08-05 Massachusetts Institute Of Technology Functionalized polyester graft copolymers
CA2400485C (en) * 2000-02-26 2014-04-29 Artecel Sciences, Inc. Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
EP2336299A1 (en) * 2001-02-14 2011-06-22 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
WO2002067867A2 (en) * 2001-02-23 2002-09-06 The University Of Pittsburgh Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
US7651684B2 (en) * 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
JP3934539B2 (ja) * 2001-12-12 2007-06-20 独立行政法人科学技術振興機構 胎盤等由来の成体又は生後組織の前駆細胞
WO2003089619A2 (en) * 2002-04-19 2003-10-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Placental derived stem cells and uses thereof
ATE524070T1 (de) * 2003-02-20 2011-09-15 Cytori Therapeutics Inc Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz- kreislauf-leiden
AU2005241008C1 (en) * 2004-04-23 2010-11-04 Bioe, Inc. Multi-Lineage Progenitor Cells
KR100747637B1 (ko) 2004-11-24 2007-08-08 전진현 포유류 배아 및 줄기세포의 미분화 상태 유지 오씨티-4 유전자 발현 억제용 이중나선 알엔에이
KR100745895B1 (ko) 2004-12-14 2007-08-02 한국생명공학연구원 인간 배아줄기세포에 특이적인 단일클론항체
KR100679642B1 (ko) 2005-11-16 2007-02-06 주식회사 알앤엘바이오 인간 지방조직 유래 다분화능 줄기세포 및 이를 함유하는세포치료제
EP1845154A1 (en) * 2006-04-12 2007-10-17 RNL Bio Co., Ltd. Multipotent stem cells derived from placenta tissue and cellular therapeutic agents comprising the same
KR100871984B1 (ko) 2006-04-12 2008-12-05 주식회사 알앤엘바이오 태반 조직 유래 다능성 줄기세포 및 이를 함유하는세포치료제
KR100788632B1 (ko) 2006-06-15 2007-12-26 주식회사 알앤엘바이오 인간 지방조직 유래 다분화능 줄기세포, 섬유아세포 및지방 또는 지방세포를 함유한 피부미용 또는 성형용조성물의 제조방법
KR100773460B1 (ko) 2006-09-22 2007-11-06 노영도 방진 및 방독 마스크
AU2008223426A1 (en) * 2007-03-01 2008-09-12 Julie G. Allickson Procurement, isolation and cryopreservation of endometrial/menstrual cells
KR101425653B1 (ko) 2007-05-02 2014-08-05 라정찬 인간 지방조직 유래 다분화능 줄기세포 및 모낭세포를함유하는 세포치료제
KR20080103637A (ko) 2007-05-25 2008-11-28 주식회사 알앤엘바이오 지방유래 줄기세포를 함유하는 사지말단부 허혈성 질환의세포치료용 조성물
CN101765657A (zh) * 2007-11-09 2010-06-30 Rnl生物技术株式会社 分离和培养来自人羊膜上皮细胞的成人干细胞的方法

Also Published As

Publication number Publication date
CA2692765A1 (en) 2009-06-04
ES2478678T3 (es) 2014-07-22
EP2247285A4 (en) 2012-05-02
PL2247285T3 (pl) 2014-11-28
JP5280451B2 (ja) 2013-09-04
KR20090056925A (ko) 2009-06-03
JP2010538059A (ja) 2010-12-09
CN101801352B (zh) 2013-04-03
MX2010000394A (es) 2010-05-13
KR101046188B1 (ko) 2011-07-04
EP2247285A2 (en) 2010-11-10
WO2009069991A2 (en) 2009-06-04
WO2009069991A3 (en) 2009-08-06
CN101801352A (zh) 2010-08-11
US20110059052A1 (en) 2011-03-10
CA2692765C (en) 2015-09-22
US20130189232A1 (en) 2013-07-25
EP2247285B1 (en) 2014-06-11
US9211306B2 (en) 2015-12-15

Similar Documents

Publication Publication Date Title
PL2247285T3 (pl) Komórkowy środek terapeutyczny na nietrzymanie moczu zawierający komórki macierzyste pochodzące z doczesnej
IL233377A (en) A matrix containing placental stem cells for the treatment of inflammatory diseases
EP2146632A4 (en) COMPOSITIONS AND METHODS FOR CELLULAR IMAGE PRESENTATION AND THERAPY
GB2446847B (en) Location of Basestation
IL208383A0 (en) Action times for handover of mobile stations
EP2007904A4 (en) PROPAGATION OF PRIMARY CELLS
HK1170258A1 (en) Expansion of nk cells nk
ZA201007762B (en) Applicator for self-expanding intravaginal urinary incontinence devices
IL186749A0 (en) Dihydrothienopyrimidines for the treatment of inflammatory diseases
EP1879578A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE
EP2292231A4 (en) THERAPEUTIC AGENT FOR SPINAL CANAL STENOSIS
ZA201000278B (en) Human umbilical tissue-derived cell compositions for the treatment of incontinence
GB0724904D0 (en) Improved soft handover for cellular radio systems
EP2434983A4 (en) CORRECTION OF URINARY INCONTINENCE DUE TO VOLTAGE
IL194826A0 (en) Compositions and methods for cellular imaging and therapy
IL214349A (en) Preparations for the treatment of cancer and the use of cellulose energy inhibitors to create them
EP1917348A4 (en) ISOLATION OF MULTIPLE LINE STEM CELLS
SI2003978T1 (sl) Alogenska celiäśna terapija za zdravljenje opurtunistiäśnih okuĺ˝b
EP2180318A4 (en) DIAGNOSTIC AGENT FOR URINARY CAT PROTEIN
GB0723504D0 (en) Treatment of eukaryotic cellular biomass
EP2412705A4 (en) NEW THERAPEUTIC AGENT FOR COGNITIVE DEFICIT
ZA200905681B (en) Therapeutic agent for urinary excretion disorder
EP1725247A4 (en) POLYPHENOLS AS AN INTRAVESICAL AGENT FOR THE PREVENTION OF TRANSITIONAL CELLULAR TUMORAL IMPLANTATION
GB2480406B (en) Location of basestation
HU0400289D0 (en) Composition for treatment of urine incontinence